US 7,528,166 B2
	Lignan derivatives
Patrik Eklund, Turku (Finland); Mervi Hiilovaara-Teijo, Riihikoski (Finland); Arja Kalapudas, Oulu (Finland); Lauri Kangas, Lieto (Finland); Anna Lindholm, Bandhagen (Sweden); Rainer Sjohölm, Piispanristi (Finland); Marja Södervall, Oulu (Finland); and Mikko Unkila, Littoinen (Finland)
Assigned to Hormos Medical Corporation, Turku (Finland)
Appl. No. 10/499,452 PCT Filed Jan. 21, 2003, PCT No. PCT/FI03/00041 § 371(c)(1), (2), (4) Date Jun. 18, 2004, PCT Pub. No. WO03/066556, PCT Pub. Date Aug. 14, 2003.
Claims priority of application No. 20020222 (FI), filed on Feb. 05, 2002; and application No. 20020563 (FI), filed on Mar. 25, 2002.
Prior Publication US 2005/0101541 A1, May 12, 2005
Int. Cl. A61K 31/341 (2006.01)

U.S. Cl. 514—461  [549/323]

2 Claims

1. Hydroxymatairesinol dibutyrate.